Relevance/NN
Epistasis/NN
Network/NN
of/IN
Gastritis/NN
for/IN
Intra-chromosomes/NNS
in/IN
the/DT
Korea/NN
Associated/VBN
Resource/NN
(/(
KARE/NN
)/)
Cohort/NN
Study/NN
./.
====================
Gastritis/NN
is/VBZ
a/DT
common/JJ
but/CC
a/DT
serious/JJ
disease/NN
with/IN
a/DT
potential/JJ
risk/NN
of/IN
developing/VBG
carcinoma/NN
./.
====================
Helicobacter/RB
pylori/NN
infection/NN
is/VBZ
reported/VBN
as/IN
the/DT
most/JJS
common/JJ
cause/VBP
of/IN
gastritis/NN
,/,
but/CC
other/JJ
genetic/JJ
and/CC
genomic/JJ
factors/NNS
exist/VBP
,/,
especially/RB
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
./.
====================
Association/NN
studies/NNS
between/IN
SNPs/NNS
and/CC
gastritis/NN
disease/NN
are/VBP
important/JJ
,/,
but/CC
results/VBZ
on/IN
epistatic/JJ
interactions/NNS
from/IN
multiple/JJ
SNPs/NNS
are/VBP
rarely/RB
found/VBN
in/IN
previous/JJ
genome-wide/NN
association/NN
(/(
GWA/NN
)/)
studies/NNS
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
performed/VBD
computational/JJ
GWA/NN
case-control/JJ
studies/NNS
for/IN
gastritis/NN
in/IN
Korea/NN
Associated/VBN
Resource/NN
(/(
KARE/NN
)/)
data/NNS
./.
====================
By/IN
transforming/VBG
the/DT
resulting/VBG
SNP/NN
epistasis/NN
network/NN
into/IN
a/DT
gene-gene/JJ
epistasis/NN
network/NN
,/,
we/PRP
also/RB
identified/VBD
potential/JJ
gene-gene/JJ
interaction/NN
factors/NNS
that/WDT
affect/VBP
the/DT
susceptibility/NN
to/TO
gastritis/NN
./.
====================
Gastritis/NN
is/VBZ
a/DT
common/JJ
disease/NN
in/IN
Korea/NN
./.
====================
There/EX
is/VBZ
a/DT
report/NN
that/IN
9.9/CD
%/NN
of/IN
Koreans/NN
have/VBP
gastritis/NN
[/(
1/CD
]/)
./.
====================
Gastritis/NN
is/VBZ
associated/VBN
with/IN
the/DT
potential/JJ
risk/NN
of/IN
developing/VBG
gastric/JJ
cancer/NN
or/CC
peptic/JJ
ulcer/NN
disease/NN
[/(
2/CD
]/)
./.
====================
A/DT
common/JJ
cause/VBP
of/IN
gastritis/NN
is/VBZ
Helicobacter/JJ
pylori/NN
infection/NN
[/(
3/CD
]/)
./.
====================
However/RB
,/,
in/IN
addition/NN
to/TO
the/DT
cause/NN
,/,
other/JJ
genetic/JJ
and/CC
genomic/JJ
factors/NNS
have/VBP
been/VBN
examined/VBN
for/IN
gastritis/NN
./.
====================
Human/JJ
leukocyte/NN
antigen/NN
class/NN
II/CD
allele/NN
is/VBZ
an/DT
important/JJ
risk/NN
factor/NN
for/IN
chronic/JJ
atrophic/JJ
gastritis/NN
and/CC
gastric/JJ
carcinoma/NN
in/IN
Koreans/NNS
[/(
4/CD
]/)
./.
====================
Moreover/RB
,/,
many/JJ
studies/NNS
have/VBP
reported/VBN
that/IN
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
,/,
including/VBG
rs1143627/NN
in/IN
interleukin-1/NN
beta/NN
(/(
IL1B/NN
)/)
,/,
rs4073/RB
in/IN
interleukin/NN
8/CD
(/(
IL8/NN
)/)
,/,
rs4986790/RB
in/IN
Toll-like/JJ
receptor/NN
4/CD
(/(
TLR4/NN
)/)
,/,
and/CC
rs16260/NN
in/IN
cadherin-1/NN
(/(
CDH1/NN
)/)
,/,
are/VBP
associated/VBN
with/IN
susceptibility/NN
to/TO
gastric/JJ
diseases/NNS
,/,
especially/RB
gastric/JJ
cancer/NN
[/(
5/CD
,/,
6/CD
,/,
7/CD
,/,
8/CD
]/)
./.
====================
The/DT
results/NNS
from/IN
SNP/NN
studies/NNS
show/VBP
the/DT
importance/NN
of/IN
research/NN
for/IN
the/DT
association/NN
between/IN
SNP/NN
and/CC
disease/NN
,/,
based/VBN
on/IN
the/DT
association/NN
and/CC
functional/JJ
relationship/NN
between/IN
gastritis/NN
and/CC
gastric/JJ
carcinoma/NN
[/(
9/CD
]/)
./.
====================
In/IN
other/JJ
words/NNS
,/,
a/DT
casual/JJ
SNP/NN
in/IN
one/CD
disease/NN
may/MD
be/VB
a/DT
genetic/JJ
factor/NN
for/IN
another/DT
disease/NN
./.
====================
However/RB
,/,
previous/JJ
studies/NNS
only/RB
targeted/VBN
the/DT
effect/NN
from/IN
each/DT
single/JJ
variation/NN
;/:
results/VBZ
have/VBP
been/VBN
rarely/RB
obtained/VBN
for/IN
high-order/JJ
genetic/JJ
interactions/NNS
in/IN
gastritis/NN
from/IN
genome-wide/NN
association/NN
(/(
GWA/NN
)/)
studies/NNS
to/TO
date/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
performed/VBD
a/DT
GWA/NN
case-control/JJ
study/NN
for/IN
gastritis/NN
using/VBG
SNP/NN
genotype/NN
data/NNS
of/IN
the/DT
Korea/NN
Associated/VBN
Resource/NN
(/(
KARE/NN
)/)
project/VBP
[/(
10/CD
]/)
./.
====================
Our/PRP$
study/NN
was/VBD
focused/VBN
on/IN
detecting/VBG
significant/JJ
epistatic/JJ
SNP-SNP/NN
interactions/NNS
and/CC
the/DT
resulting/VBG
gene-gene/NN
interactions/NNS
that/WDT
are/VBP
putative/JJ
causal/JJ
factors/NNS
in/IN
gastritis/NN
./.
====================
A/DT
validation/NN
and/CC
functional/JJ
analysis/NN
of/IN
the/DT
result/NN
was/VBD
performed/VBN
on/IN
the/DT
obtained/VBN
relevance/NN
gene-gene/NN
epistasis/NN
network/NN
./.
====================
Our/PRP$
network/NN
construction/NN
method/NN
is/VBZ
based/VBN
on/IN
the/DT
previous/JJ
relevance/NN
network/NN
approach/NN
[/(
11/CD
]/)
./.
====================
To/TO
measure/VB
the/DT
strength/NN
of/IN
the/DT
association/NN
between/IN
a/DT
pair/NN
of/IN
SNPs/NNS
and/CC
gastritis/NN
,/,
we/PRP
used/VBD
the/DT
mutual/JJ
information/NN
that/IN
has/VBZ
shown/VBN
to/TO
be/VB
effective/JJ
in/IN
detecting/VBG
epistasis/NN
in/IN
case-control/JJ
GWA/NN
studies/NNS
[/(
12/CD
,/,
13/CD
]/)
./.
====================
An/DT
efficient/JJ
permutation/NN
scheme/NN
was/VBD
adopted/VBN
to/TO
extract/NN
significant/JJ
interaction/NN
pairs/NNS
,/,
and/CC
we/PRP
also/RB
approximated/VBD
the/DT
p-values/NNS
by/IN
exploiting/VBG
the/DT
relationship/NN
between/IN
the/DT
mutual/JJ
information/NN
value/NN
and/CC
the/DT
χ2/NN
value/NN
[/(
14/CD
]/)
./.
====================
We/PRP
further/RB
transformed/VBN
this/DT
SNP/NN
network/NN
into/IN
a/DT
relevant/JJ
gene-gene/NN
epistasis/NN
network/NN
to/TO
validate/VB
the/DT
biological/JJ
significance/NN
of/IN
our/PRP$
findings/NNS
./.
====================
A/DT
functional/JJ
analysis/NN
was/VBD
performed/VBN
on/IN
the/DT
gene-gene/NN
network/NN
,/,
and/CC
the/DT
topological/JJ
properties/NNS
of/IN
the/DT
network/NN
were/VBD
also/RB
investigated/VBD
./.
====================
Pre-processing/VBG
for/IN
KARE/NN
data/NNS
====================
The/DT
KARE/NN
genotype/NN
data/NNS
we/PRP
used/VBD
in/IN
the/DT
study/NN
initially/RB
consisted/VBN
of/IN
352,228/CD
SNPs/NNS
and/CC
8,842/CD
samples/NNS
after/IN
the/DT
screening/NN
by/IN
genotype/NN
calling/JJ
and/CC
quality/NN
control/NN
performed/VBN
[/(
10/CD
]/)
./.
====================
We/PRP
performed/VBD
the/DT
following/VBG
additional/JJ
stages/NNS
of/IN
pre-processing/VBG
./.
====================
First/RB
,/,
we/PRP
selected/VBD
case-control/JJ
samples/NNS
based/VBN
on/IN
the/DT
survey/NN
of/IN
the/DT
disease/NN
history/JJ
of/IN
the/DT
patients/NNS
,/,
which/WDT
was/VBD
carried/VBN
out/RP
in/IN
the/DT
KARE/NN
project/VB
./.
====================
In/IN
the/DT
first/JJ
stage/NN
,/,
we/PRP
collected/VBD
1,885/CD
patients/NNS
who/WP
self-reported/VBD
that/DT
they/PRP
had/VBD
gastritis/NN
in/IN
the/DT
past/NN
as/IN
cases/NNS
./.
====================
We/PRP
also/RB
found/VBD
4,117/CD
individuals/NNS
who/WP
self-reported/VBD
that/DT
they/PRP
had/VBD
no/DT
history/JJ
of/IN
having/VBG
gastritis/NN
or/CC
any/DT
other/JJ
diseases/NNS
./.
====================
Among/IN
those/DT
patients/NNS
,/,
we/PRP
randomly/RB
selected/VBN
1,885/CD
individuals/NNS
as/IN
controls/NNS
to/TO
avoid/VB
bias/NNS
in/IN
the/DT
study/NN
./.
====================
After/IN
the/DT
selection/NN
of/IN
case-control/JJ
patients/NNS
,/,
we/PRP
filtered/VBD
out/IN
SNPs/NNS
that/DT
corresponded/VBD
to/TO
the/DT
following/VBG
conditions/NNS
:/:
minor/JJ
allele/NN
frequency/NN
</JJR
0.01/CD
in/IN
each/DT
group/NN
[/(
15/CD
]/)
,/,
pairwise/JJ
linkage/NN
disequilibrium/NN
r2/NN
>/JJR
0.8/CD
[/(
16/CD
]/)
,/,
and/CC
SNPs/NNS
in/IN
the/DT
X/NN
chromosome/NN
./.
====================
PLINK/NN
[/(
17/CD
]/)
was/VBD
used/VBN
for/IN
the/DT
calculation/NN
of/IN
these/DT
values/NNS
./.
====================
The/DT
resulting/VBG
dataset/NN
consisted/VBD
of/IN
185,426/CD
SNPs/NNS
and/CC
3,770/CD
samples/NNS
for/IN
the/DT
case-control/JJ
study/NN
./.
====================
Mutual/JJ
information/NN
====================
We/PRP
used/VBD
mutual/JJ
information/NN
measures/NNS
to/TO
assess/VB
the/DT
strength/NN
of/IN
the/DT
association/NN
between/IN
a/DT
pair/NN
of/IN
SNPs/NNS
and/CC
the/DT
disease/NN
status/NN
of/IN
gastritis/NN
./.
====================
Mutual/JJ
information/NN
has/VBZ
been/VBN
widely/RB
used/VBN
to/TO
measure/VB
dependence/NN
or/CC
independence/NN
between/IN
two/CD
random/JJ
variables/NNS
[/(
11/CD
,/,
12/CD
,/,
18/CD
,/,
19/CD
]/)
./.
====================
It/PRP
is/VBZ
a/DT
non-parametric/JJ
measure/VB
and/CC
is/VBZ
able/JJ
to/TO
detect/VB
both/CC
linear/JJ
and/CC
non-linear/JJ
associations/NNS
[/(
14/CD
]/)
./.
====================
This/DT
measure/NN
is/VBZ
based/VBN
on/IN
Shannon/NN
's/POS
entropy/NN
,/,
H/NN
(/(
X/NN
)/)
=/JJ
Σx∈X/NN
-/:
p/NN
(/(
x/CC
)/)
log/NN
(/(
p/NN
(/(
x/CC
)/)
)/)
,/,
which/WDT
shows/VBZ
the/DT
uncertainty/JJ
of/IN
the/DT
random/JJ
variable/JJ
X/NN
./.
====================
Mutual/JJ
information/NN
I/NN
(/(
X/NN
;/:
Y/NN
)/)
between/IN
random/JJ
variables/NNS
X/NN
and/CC
Y/NN
is/VBZ
defined/VBN
by/IN
the/DT
composition/NN
of/IN
entropy/JJ
as/IN
follows/VBZ
:/:
I/CD
(/(
X/NN
;/:
Y/NN
)/)
=/JJ
H/NN
(/(
X/NN
)/)
+/CC
H/NN
(/(
Y/NN
)/)
-/:
H/NN
(/(
X/NN
,/,
Y/NN
)/)
./.
====================
H/NN
(/(
X/NN
)/)
,/,
H/NN
(/(
Y/NN
)/)
denote/VBP
entropies/VBZ
for/IN
the/DT
random/JJ
variables/NNS
X/NN
,/,
Y/NN
,/,
and/CC
H/NN
(/(
X/NN
,/,
Y/NN
)/)
denotes/VBZ
the/DT
joint/NN
entropy/RB
of/IN
the/DT
two/CD
random/JJ
variables/NNS
as/IN
follows/VBZ
:/:
H/NN
(/(
X/NN
,/,
Y/NN
)/)
=Σx∈XΣy∈Y/JJ
-/:
p/NN
(/(
x/CC
,/,
y/RB
)/)
log/NN
(/(
p/NN
(/(
x/CC
,/,
y/RB
)/)
)/)
./.
====================
A/DT
high/JJ
mutual/JJ
information/NN
value/NN
indicates/VBZ
a/DT
strong/JJ
association/NN
between/IN
two/CD
random/JJ
variables/NNS
./.
====================
The/DT
measure/NN
can/MD
also/RB
be/VB
extended/VBN
to/TO
assess/VB
the/DT
strength/NN
of/IN
association/NN
between/IN
a/DT
pair/NN
of/IN
SNPs/NNS
and/CC
a/DT
phenotype/NN
./.
====================
The/DT
extended/JJ
version/NN
of/IN
mutual/JJ
information/NN
is/VBZ
as/IN
follows/VBZ
:/:
I/CD
(/(
X1/NN
,/,
X2/NN
;/:
Y/NN
)/)
=/JJ
H/NN
(/(
X1/NN
,/,
X2/NN
)/)
+/CC
H/NN
(/(
Y/NN
)/)
-/:
H/NN
(/(
X1/NN
,/,
X2/NN
,/,
Y/NN
)/)
,/,
where/WRB
X1/NN
and/CC
X2/NN
are/VBP
random/JJ
variables/NNS
for/IN
two/CD
SNPs/NNS
,/,
and/CC
Y/NN
denotes/VBZ
random/JJ
variables/NNS
for/IN
the/DT
disease/NN
./.
====================
In/IN
our/PRP$
recent/JJ
work/NN
[/(
12/CD
]/)
,/,
we/PRP
have/VBP
shown/VBN
that/IN
this/DT
measure/NN
could/MD
identify/VB
high-order/JJR
epistatic/JJ
interactions/NNS
both/CC
with/IN
and/CC
without/IN
marginal/JJ
effects/NNS
by/IN
using/VBG
simulation/JJ
models/NNS
,/,
such/JJ
as/IN
in/IN
Culverhouse/NN
et/FW
al/JJ
./.
====================
's/POS
[/(
20/CD
]/)
and/CC
Velez/NNP
et/FW
al/JJ
./.
====================
's/POS
studies/NNS
[/(
21/CD
]/)
./.
====================
As/IN
the/DT
genotype/NN
and/CC
disease/NN
status/NN
are/VBP
represented/VBN
as/IN
discrete/JJ
values/NNS
,/,
it/PRP
is/VBZ
more/RBR
convenient/JJ
to/TO
consider/VB
the/DT
random/JJ
variables/NNS
as/IN
a/DT
partition/NN
of/IN
the/DT
combination/NN
of/IN
the/DT
genotypes/NNS
and/CC
disease/NN
status/NN
./.
====================
Then/RB
,/,
the/DT
entropy/NN
of/IN
a/DT
random/JJ
variable/JJ
X/NN
can/MD
be/VB
represented/VBN
in/IN
terms/NNS
of/IN
the/DT
partition/NN
as/IN
follows/VBZ
:/:
====================
where/WRB
X/NN
=/JJ
{/CD
A1/NN
,/,
A2/NN
,/,
…/NNP
,/,
An/DT
}/JJ
is/VBZ
a/DT
partition/NN
on/IN
the/DT
set/NN
of/IN
samples/NNS
S/NN
=/JJ
{/CD
A1∪A2∪…∪An/NN
}/CD
,/,
and/CC
no/DT
intersections/NNS
exist/VBP
between/IN
elements/NNS
in/IN
the/DT
partition/NN
./.
====================
The/DT
joint/NN
entropy/RB
of/IN
two/CD
random/JJ
variables/NNS
for/IN
the/DT
partition/NN
of/IN
S/NN
,/,
X/NN
=/JJ
{/CD
A1/NN
,/,
A2/NN
,/,
…/NNP
,/,
An/DT
}/JJ
and/CC
Y/NN
=/JJ
{/CD
B1/NN
,/,
B2/NN
,/,
…/NNP
,/,
Bm/NNP
}/CD
is/VBZ
defined/VBN
as/IN
follows/VBZ
:/:
====================
The/DT
entropy/JJ
also/RB
can/MD
be/VB
extended/VBN
to/TO
the/DT
joint/NN
entropy/NN
of/IN
multiple/JJ
random/JJ
variables/NNS
(/(
e.g./FW
,/,
3/CD
or/CC
4/CD
SNPs/NNS
)/)
naturally/RB
./.
====================
Extraction/NN
of/IN
statistically/RB
significant/JJ
epistatic/JJ
interactions/NNS
====================
As/IN
mentioned/VBN
above/JJ
,/,
mutual/JJ
information/NN
is/VBZ
a/DT
non-parametric/JJ
measure/VB
,/,
and/CC
the/DT
distribution/NN
of/IN
values/NNS
from/IN
the/DT
population/NN
is/VBZ
unknown/JJ
;/:
therefore/RB
,/,
it/PRP
is/VBZ
difficult/JJ
to/TO
show/VB
the/DT
statistical/JJ
significance/NN
of/IN
values/NNS
calculated/VBN
by/IN
this/DT
measure/NN
./.
====================
Rather/RB
than/IN
doing/JJ
the/DT
computationally/RB
too-expensive/JJ
permutation/NN
tests/NNS
for/IN
every/RB
pair/NN
of/IN
SNPs/NNS
,/,
which/WDT
causes/VBZ
severe/JJ
multiple/JJ
testing/VBG
issues/NNS
when/WRB
applied/VBN
to/TO
GWA/NN
studies/NNS
,/,
we/PRP
adopted/VBD
the/DT
alternative/JJ
permutation/NN
scheme/NN
proposed/VBN
[/(
11/CD
]/)
./.
====================
First/RB
,/,
we/PRP
replicated/VBD
30/CD
permutations/NNS
for/IN
disease/NN
status/NN
in/IN
case-control/JJ
samples/NNS
./.
====================
For/IN
every/RB
possible/JJ
pair/NN
of/IN
given/VBN
SNPs/NNS
,/,
we/PRP
calculated/VBD
mutual/JJ
information/NN
of/IN
SNPs/NNS
with/IN
the/DT
permutated/JJ
disease/NN
status/NN
labels/VBZ
and/CC
obtained/VBN
the/DT
average/NN
value/NN
from/IN
30/CD
replications/NNS
./.
====================
θ/RB
denotes/VBZ
the/DT
maximum/NN
value/NN
of/IN
the/DT
averages/NNS
./.
====================
If/IN
a/DT
mutual/JJ
information/NN
value/NN
between/IN
SNPs/NNS
and/CC
the/DT
phenotype/NN
from/IN
real/JJ
data/NNS
is/VBZ
higher/JJR
than/IN
θ/DT
,/,
then/RB
we/PRP
consider/VBP
that/DT
the/DT
pair/NN
of/IN
SNPs/NNS
shows/VBZ
a/DT
more/RBR
significant/JJ
association/NN
with/IN
gastritis/NN
than/IN
a/DT
random/JJ
association/NN
./.
====================
To/TO
further/RBR
assess/VB
the/DT
statistical/JJ
significance/NN
of/IN
the/DT
identified/VBN
SNP/NN
pairs/NNS
,/,
we/PRP
approximated/VBD
the/DT
p-values/NNS
of/IN
the/DT
SNP/NN
pairs/NNS
by/IN
exploiting/VBG
the/DT
following/VBG
relationship/NN
between/IN
χ2/NN
value/NN
and/CC
mutual/JJ
information/NN
[/(
14/CD
]/)
:/:
χ2/CD
~/CD
2Nln2·I/JJ
(/(
X1/NN
,/,
X2/NN
;/:
Y/NN
)/)
,/,
where/WRB
N/NN
denotes/VBZ
the/DT
number/NN
of/IN
patients/NNS
in/IN
the/DT
study/NN
./.
====================
Relevance/NN
network/NN
construction/NN
and/CC
assessment/NN
of/IN
significance/NN
====================
Network/NN
analysis/NN
is/VBZ
a/DT
powerful/JJ
tool/NN
to/TO
understand/VB
biological/JJ
systems/NNS
./.
====================
Given/IN
the/DT
significant/JJ
epistatic/JJ
interactions/NNS
between/IN
SNP/NN
pairs/NNS
and/CC
disease/NN
status/NN
detected/VBN
by/IN
the/DT
permutation/NN
scheme/NN
,/,
we/PRP
constructed/VBD
SNP-SNP/NN
epistatic/JJ
interaction/NN
networks/NNS
,/,
where/WRB
SNP/NN
represents/VBZ
the/DT
node/NN
and/CC
the/DT
significant/JJ
interaction/NN
between/IN
SNP/NN
pairs/NNS
represents/VBZ
the/DT
edge/NN
./.
====================
However/RB
,/,
it/PRP
is/VBZ
difficult/JJ
to/TO
assess/VB
the/DT
biological/JJ
significance/NN
of/IN
the/DT
interaction/NN
networks/NNS
directly/RB
because/IN
of/IN
the/DT
lack/NN
of/IN
interaction/NN
databases/NNS
for/IN
SNPs/NNS
./.
====================
To/TO
overcome/VB
this/DT
limitation/NN
,/,
we/PRP
directly/RB
mapped/VBD
these/DT
networks/NNS
into/IN
a/DT
gene-gene/JJ
relevance/NN
network/NN
./.
====================
Fig/NN
./.
====================
1/CD
represents/VBZ
a/DT
brief/JJ
scheme/NN
of/IN
how/WRB
to/TO
map/VB
the/DT
network/NN
./.
====================
Suppose/DT
that/DT
some/DT
SNPs/NNS
map/VBP
directly/RB
to/TO
genes/NNS
A/DT
and/CC
B/NN
,/,
and/CC
there/EX
are/VBP
at/IN
least/JJS
two/CD
SNPs/NNS
that/DT
have/VBP
significant/JJ
interactions/NNS
for/IN
disease/NN
status/NN
./.
====================
If/IN
one/CD
SNP/NN
maps/VBZ
to/TO
gene/NN
A/NN
and/CC
another/DT
SNP/NN
maps/VBZ
to/TO
gene/NN
B/NN
,/,
then/RB
we/PRP
consider/VBP
that/DT
genes/NNS
A/DT
and/CC
B/NN
have/VBP
a/DT
unidirectional/JJ
edge/NN
./.
====================
The/DT
weight/NN
of/IN
the/DT
edge/NN
is/VBZ
defined/VBN
by/IN
number/NN
of/IN
the/DT
interacting/VBG
SNP/NN
pairs/NNS
./.
====================
For/IN
example/NN
,/,
in/IN
Fig/NN
./.
====================
1/CD
,/,
there/EX
are/VBP
four/CD
SNP/NN
interactions/NNS
between/IN
gene/NN
A/NN
and/CC
gene/NN
B/NN
./.
====================
Thus/RB
,/,
we/PRP
consider/VBP
that/DT
gene/NN
A/NN
and/CC
gene/NN
B/NN
have/VBP
an/DT
edge/NN
,/,
the/DT
weight/NN
of/IN
which/WDT
is/VBZ
4/CD
in/IN
the/DT
gene-gene/NN
network/NN
./.
====================
Finally/RB
,/,
the/DT
top/NN
5/CD
%/NN
edges/NNS
having/VBG
the/DT
largest/JJS
edge/NN
weights/NNS
are/VBP
used/VBN
in/IN
the/DT
biological/JJ
validation/NN
and/CC
topological/JJ
investigation/NN
./.
====================
We/PRP
constructed/VBD
a/DT
gene-gene/JJ
network/NN
for/IN
each/DT
chromosome/NN
showing/VBG
intra-chromosome/JJ
interactions/NNS
./.
====================
We/PRP
measured/VBD
the/DT
network/NN
topologies/NNS
of/IN
each/DT
network/NN
using/VBG
Cytoscape/NN
[/(
22/CD
]/)
and/CC
also/RB
ran/VBP
a/DT
gene/NN
ontology/NN
(/(
GO/NN
)/)
enrichment/JJ
analysis/NN
for/IN
sets/NNS
of/IN
genes/NNS
in/IN
the/DT
network/NN
./.
====================
We/PRP
used/VBD
DAVID/NN
[/(
23/CD
]/)
to/TO
validate/VB
the/DT
biological/JJ
significance/NN
of/IN
the/DT
networks/NNS
./.
====================
Fig/NN
./.
====================
2/CD
illustrates/VBZ
the/DT
overall/JJ
analysis/NN
scheme/VBP
used/VBN
in/IN
this/DT
study/NN
./.
====================
Statistically/RB
significant/JJ
epistatic/JJ
interactions/NNS
in/IN
each/DT
chromosome/NN
====================
We/PRP
ran/VBP
the/DT
permutation/NN
method/NN
for/IN
each/DT
individual/JJ
chromosome/NN
separately/RB
./.
====================
As/IN
a/DT
result/NN
,/,
we/PRP
obtained/VBD
SNP/NN
pairs/NNS
that/DT
were/VBD
non-randomly/RB
associated/VBN
with/IN
the/DT
status/NN
of/IN
gastritis/NN
for/IN
the/DT
given/VBN
patients/NNS
./.
====================
Fig/NN
./.
====================
3/CD
shows/VBZ
the/DT
number/NN
of/IN
such/JJ
SNP/NN
pairs/NNS
for/IN
each/DT
chromosome/NN
./.
====================
We/PRP
found/VBD
that/IN
there/EX
were/VBD
approximately/RB
2/CD
%/NN
-4/CD
%/NN
associated/VBN
pairs/NNS
among/IN
all/DT
possible/JJ
pairs/NNS
in/IN
the/DT
chromosomes/NNS
./.
====================
We/PRP
then/RB
calculated/VBN
the/DT
p-value/JJ
for/IN
each/DT
SNP/NN
pair/NN
by/IN
using/VBG
the/DT
approximation/NN
scheme/NN
[/(
14/CD
]/)
and/CC
under/IN
Bonferroni/NNP
correction/NN
[/(
24/CD
]/)
./.
====================
Table/JJ
1/CD
shows/VBZ
the/DT
number/NN
of/IN
statistically/RB
significant/JJ
SNP/NN
pairs/NNS
within/IN
each/DT
chromosome/NN
./.
====================
Significant/JJ
SNP/NN
pairs/NNS
and/CC
p-values/NNS
are/VBP
listed/VBN
in/IN
Supplementary/JJ
Table/JJ
1/CD
./.
====================
In/IN
total/JJ
,/,
293/CD
SNP/NN
pairs/NNS
showed/VBD
statistical/JJ
significance/NN
in/IN
the/DT
study/NN
./.
====================
Chromosomes/NNS
9/CD
and/CC
15/CD
had/VBD
many/JJ
significant/JJ
pairs/NNS
,/,
but/CC
many/JJ
of/IN
those/DT
pairs/NNS
included/VBD
SNPs/NNS
with/IN
marginal/JJ
effects/NNS
(/(
rs169730/NN
in/IN
chromosome/NN
9/CD
,/,
rs493971/NN
in/IN
chromosome/NN
15/CD
)/)
./.
====================
There/EX
were/VBD
few/JJ
significant/JJ
SNP/NN
pairs/NNS
within/IN
the/DT
chromosomes/NNS
,/,
and/CC
these/DT
pairs/NNS
were/VBD
not/RB
found/VBN
in/IN
previous/JJ
studies/NNS
of/IN
gastric/JJ
disease/NN
;/:
therefore/RB
,/,
further/RB
investigation/NN
of/IN
the/DT
pairs/NNS
is/VBZ
needed/VBN
to/TO
assess/VB
their/PRP$
biological/JJ
significance/NN
./.
====================
Network/NN
topologies/NNS
====================
Table/JJ
2/CD
summarizes/VBZ
the/DT
results/NNS
of/IN
the/DT
network/NN
topology/NN
measures/NNS
(/(
number/NN
of/IN
nodes/NNS
and/CC
edges/VBZ
,/,
clustering/NN
coefficient/JJ
,/,
and/CC
network/NN
centralization/NN
)/)
for/IN
the/DT
gene-gene/NN
interaction/NN
network/NN
for/IN
each/DT
chromosome/NN
./.
====================
The/DT
table/JJ
shows/VBZ
that/IN
all/DT
chromosomes/NNS
showed/VBD
similar/JJ
properties/NNS
:/:
the/DT
number/NN
of/IN
edges/NNS
is/VBZ
10-30-fold/JJ
higher/JJR
than/IN
the/DT
number/NN
of/IN
nodes/NNS
,/,
and/CC
the/DT
measurements/NNS
reveal/VBP
high/JJ
clustering/NN
coefficients/NNS
and/CC
network/NN
centralization/NN
./.
====================
Additionally/RB
,/,
every/RB
network/NN
from/IN
each/DT
chromosome/NN
consisted/VBD
of/IN
only/RB
one/CD
component/NN
./.
====================
Figs/NNS
./.
====================
4/CD
and/CC
5/CD
present/JJ
the/DT
structure/NN
of/IN
networks/NNS
showing/VBG
the/DT
highest/JJS
values/NNS
for/IN
the/DT
measures/NNS
,/,
especially/RB
the/DT
clustering/NN
coefficient/JJ
and/CC
network/NN
centralization/NN
./.
====================
In/IN
the/DT
real/JJ
world/NN
,/,
many/JJ
biological/JJ
networks/NNS
show/VBP
high/JJ
average/NN
clustering/NN
coefficients/NNS
[/(
25/CD
]/)
./.
====================
The/DT
network/NN
in/IN
chromosome/NN
18/CD
showed/VBD
the/DT
highest/JJS
clustering/NN
coefficient/JJ
,/,
and/CC
we/PRP
found/VBD
some/DT
hub/JJ
genes/NNS
in/IN
the/DT
network/NN
that/DT
were/VBD
reported/VBN
to/TO
be/VB
associated/VBN
with/IN
gastric/JJ
disease/NN
./.
====================
For/IN
example/NN
,/,
Uchino/NN
et/FW
al/JJ
./.
====================
[/(
26/CD
]/)
reported/VBD
frequent/JJ
loss/NN
of/IN
heterozygosity/NN
at/IN
the/DT
deleted/JJ
in/IN
colorectal/JJ
carcinoma/NN
(/(
DCC/NN
)/)
locus/NN
in/IN
gastric/JJ
cancer/NN
./.
====================
Higher/JJ
network/NN
centralization/NN
values/NNS
show/VBP
that/IN
hub/JJ
genes/NNS
highly/RB
affect/VB
the/DT
network/NN
[/(
27/CD
]/)
./.
====================
In/IN
other/JJ
words/NNS
,/,
if/IN
the/DT
hubs/NNS
are/VBP
removed/VBN
,/,
then/RB
the/DT
network/NN
may/MD
divide/VB
into/IN
several/JJ
components/NNS
./.
====================
The/DT
network/NN
in/IN
chromosome/NN
20/CD
showed/VBD
the/DT
highest/JJS
value/NN
for/IN
the/DT
centralization/NN
measure/VB
./.
====================
In/IN
the/DT
network/NN
receptor-type/JJ
tyrosine-protein/JJ
phosphatase/NN
T/NN
(/(
PTPRT/NN
)/)
,/,
one/CD
of/IN
the/DT
hub/JJ
genes/NNS
was/VBD
reported/VBN
to/TO
be/VB
one/CD
of/IN
15/CD
genes/NNS
in/IN
CpG/NN
islands/NNS
showing/VBG
significant/JJ
differential/JJ
methylation/NN
in/IN
gastric/JJ
carcinoma/NN
[/(
28/CD
]/)
./.
====================
From/IN
the/DT
results/NNS
,/,
we/PRP
determined/VBD
that/IN
there/EX
were/VBD
many/JJ
close/JJ
gene-gene/NN
interactions/NNS
derived/VBN
from/IN
SNP-SNP/NN
interactions/NNS
for/IN
gastritis/NN
and/CC
that/IN
if/IN
a/DT
gene/NN
had/VBD
a/DT
high/JJ
degree/NN
in/IN
the/DT
network/NN
,/,
then/RB
this/DT
gene/NN
was/VBD
connected/VBN
to/TO
other/JJ
genes/NNS
with/IN
which/WDT
it/PRP
had/VBD
frequent/JJ
SNP-SNP/NN
interactions/NNS
./.
====================
We/PRP
also/RB
found/VBD
this/DT
tendency/NN
in/IN
most/JJS
chromosomes/NNS
./.
====================
Enrichment/NN
analysis/NN
====================
We/PRP
ran/VBP
an/DT
enrichment/JJ
analysis/NN
of/IN
the/DT
gene-gene/NN
interaction/NN
network/NN
for/IN
GO/NN
using/VBG
DAVID/NN
[/(
23/CD
]/)
./.
====================
Table/JJ
3/CD
summarizes/VBZ
the/DT
significantly/RB
enriched/JJ
terms/NNS
from/IN
DAVID/NN
./.
====================
Every/RB
term/NN
that/DT
was/VBD
annotated/VBN
in/IN
the/DT
table/JJ
was/VBD
significant/JJ
under/IN
a/DT
false/JJ
discovery/NN
rate/NN
(/(
FDR/NN
)/)
-based/JJ
correction/NN
(/(
p/NN
</JJR
0.05/CD
after/IN
adjustment/JJ
)/)
./.
====================
Chromosome/NN
19/CD
had/VBD
the/DT
most/JJS
enriched/JJ
terms/NNS
among/IN
chromosomes/NNS
,/,
and/CC
these/DT
terms/NNS
were/VBD
related/JJ
to/TO
regulation/NN
(/(
biological/JJ
process/NN
)/)
and/CC
binding/NN
(/(
molecular/JJ
function/NN
)/)
./.
====================
Fig/NN
./.
====================
6/CD
presents/VBZ
the/DT
internal/JJ
structure/NN
of/IN
the/DT
sub-network/NN
for/IN
transcription/NN
(/(
GO:0006350/NN
)/)
in/IN
chromosome/NN
19/CD
./.
====================
This/DT
network/NN
has/VBZ
many/JJ
zinc/NN
finger/NN
(/(
ZNF/NN
)/)
family/NN
genes/NNS
./.
====================
Taniuchi/NN
et/FW
al/JJ
./.
====================
[/(
29/CD
]/)
reported/VBD
that/IN
zinc-binding/JJ
protein-89/NN
(/(
ZBP-89/NN
)/)
,/,
which/WDT
is/VBZ
related/JJ
to/TO
the/DT
ZNF/NN
gene/NN
family/NN
and/CC
is/VBZ
a/DT
Krüppel-type/JJ
zinc/NN
finger/NN
protein/NN
,/,
is/VBZ
overexpressed/VBN
in/IN
gastric/JJ
cancer/NN
patients/NNS
./.
====================
Additionally/RB
,/,
interleukin-1/NN
receptor/NN
activity/NN
(/(
GO:0004908/CD
)/)
was/VBD
significantly/RB
enriched/JJ
in/IN
chromosome/NN
2/CD
./.
====================
Fig/NN
./.
====================
7/CD
presents/VBZ
the/DT
internal/JJ
structure/NN
of/IN
the/DT
gene-gene/NN
relevance/NN
network/NN
for/IN
the/DT
GO/NN
terms/NNS
./.
====================
As/IN
mentioned/VBN
in/IN
the/DT
introduction/NN
,/,
interleukin/NN
family/NN
genes/NNS
and/CC
intra-SNPs/NNS
were/VBD
reported/VBN
[/(
5/CD
,/,
7/CD
]/)
;/:
therefore/RB
,/,
these/DT
genes/NNS
and/CC
SNPs/NNS
are/VBP
associated/VBN
with/IN
the/DT
susceptibility/NN
to/TO
gastric/JJ
cancer/NN
./.
====================
Genes/NNS
that/WDT
were/VBD
enriched/VBN
in/IN
the/DT
GO/NN
terms/NNS
were/VBD
not/RB
connected/VBN
in/IN
the/DT
relevance/NN
gene-gene/NN
network/NN
;/:
still/RB
,/,
these/DT
genes/NNS
had/VBD
few/JJ
SNP-SNP/NN
interactions/NNS
with/IN
every/RB
other/JJ
gene/NN
(/(
weight/NN
equal/JJ
or/CC
less/RBR
than/IN
11/CD
)/)
./.
====================
We/PRP
also/RB
ran/VBP
an/DT
enrichment/JJ
analysis/NN
for/IN
the/DT
Kyoto/NN
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
(/(
KEGG/NN
)/)
pathway/NN
[/(
30/CD
]/)
,/,
but/CC
no/DT
terms/NNS
were/VBD
significant/JJ
under/IN
FDR-based/JJ
adjustment/JJ
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
applied/VBD
a/DT
simple/JJ
but/CC
powerful/JJ
method/NN
to/TO
detect/VB
epistatic/JJ
interactions/NNS
that/WDT
distinguish/VBP
gastritis/NN
patients/NNS
from/IN
controls/NNS
./.
====================
We/PRP
found/VBD
several/JJ
putative/JJ
SNP-SNP/NN
interactions/NNS
using/VBG
the/DT
mutual/JJ
information/NN
measure/VB
./.
====================
Additionally/RB
,/,
relevance/NN
gene-gene/NN
interaction/NN
networks/NNS
that/DT
are/VBP
derived/VBN
from/IN
epistatic/JJ
interactions/NNS
show/VBP
high/JJ
clustering/NN
coefficients/NNS
and/CC
centralization/NN
./.
====================
We/PRP
found/VBD
that/IN
some/DT
sub-networks/NNS
in/IN
the/DT
recovered/VBN
network/NN
had/VBD
biological/JJ
significance/NN
for/IN
gastric/JJ
disease/NN
from/IN
the/DT
GO/NN
enrichment/JJ
analysis/NN
./.
====================
However/RB
,/,
we/PRP
did/VBD
not/RB
find/VB
these/DT
results/NNS
to/TO
have/VB
direct/JJ
associations/NNS
with/IN
gastritis/NN
,/,
because/IN
gastritis/NN
has/VBZ
been/VBN
less/RBR
extensively/RB
studied/VBN
than/IN
other/JJ
gastric/JJ
diseases/NNS
,/,
such/JJ
as/IN
gastric/JJ
cancer/NN
or/CC
ulcer/JJ
./.
====================
We/PRP
expect/VBP
that/DT
future/JJ
studies/NNS
on/IN
gastritis/NN
will/MD
be/VB
necessary/JJ
to/TO
validate/VB
the/DT
results/NNS
from/IN
our/PRP$
study/NN
./.
====================
In/IN
this/DT
study/NN
,/,
only/RB
intra-chromosome/JJ
interactions/NNS
were/VBD
considered/VBN
./.
====================
We/PRP
expect/VBP
that/DT
if/IN
we/PRP
extend/VBP
the/DT
method/NN
to/TO
inter-chromosomal/JJ
analyses/NNS
,/,
this/DT
could/MD
increase/VB
the/DT
chances/NNS
of/IN
finding/NN
novel/JJ
sub-networks/NNS
that/DT
are/VBP
enriched/VBN
in/IN
pathways/NNS
for/IN
gastritis/NN
./.
====================
However/RB
,/,
this/DT
extension/NN
will/MD
impose/VB
a/DT
computational/JJ
burden/NN
and/CC
increase/VBP
the/DT
type/NN
I/CD
error/NN
;/:
therefore/RB
,/,
the/DT
development/NN
of/IN
a/DT
more/RBR
flexible/JJ
framework/NN
is/VBZ
needed/VBN
to/TO
resolve/VB
this/DT
issue/NN
./.
====================
Scheme/DT
for/IN
mapping/VBG
the/DT
SNP-SNP/NN
interaction/NN
network/NN
onto/IN
the/DT
gene-gene/NN
epistasis/NN
network/NN
./.
====================
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Illustration/NN
of/IN
the/DT
network/NN
construction/NN
method/NN
./.
====================
GO/NN
,/,
gene/NN
ontology/NN
;/:
M.I./NNP
,/,
mutual/JJ
information/NN
;/:
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Number/NN
of/IN
significant/JJ
single-nucleotide/JJ
polymorphism/NN
pairs/NNS
for/IN
each/DT
chromosome/NN
./.
====================
Graphical/JJ
visualization/NN
of/IN
the/DT
gene-gene/NN
interaction/NN
network/NN
in/IN
chromosome/NN
18/CD
,/,
which/WDT
shows/VBZ
the/DT
highest/JJS
clustering/NN
coefficient/JJ
(/(
0.848/CD
)/)
./.
====================
Red/VBN
edges/NNS
represents/VBZ
frequent/JJ
SNPSNP/NN
interactions/NNS
between/IN
two/CD
genes/NNS
(/(
>/JJR
100/CD
)/)
./.
====================
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Graphical/JJ
visualization/NN
of/IN
gene-gene/NN
interaction/NN
network/NN
in/IN
chromosome/NN
20/CD
,/,
which/WDT
shows/VBZ
the/DT
highest/JJS
network/NN
centralization/NN
(/(
0.953/CD
)/)
./.
====================
Red/VBN
edges/NNS
represent/VBP
frequent/JJ
SNPSNP/NN
interactions/NNS
between/IN
two/CD
genes/NNS
(/(
>/JJR
100/CD
)/)
./.
====================
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Graphical/JJ
visualization/NN
of/IN
the/DT
internal/JJ
structure/NN
of/IN
the/DT
sub-network/NN
,/,
which/WDT
consists/VBZ
of/IN
genes/NNS
related/JJ
to/TO
transcription/NN
(/(
GO:0006350/NN
)/)
./.
====================
Red/VBN
edges/NNS
represent/VBP
frequent/JJ
SNP-SNP/NN
interactions/NNS
between/IN
two/CD
genes/NNS
(/(
>/JJR
100/CD
)/)
./.
====================
GO/NN
,/,
gene/NN
ontology/NN
;/:
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Graphical/JJ
visualization/NN
of/IN
the/DT
internal/JJ
structure/NN
of/IN
the/DT
sub-network/NN
,/,
which/WDT
consists/VBZ
of/IN
genes/NNS
related/JJ
to/TO
interleukin-1/NN
receptor/NN
activity/NN
(/(
GO:0004908/CD
)/)
./.
====================
Red/VBN
edges/NNS
represent/VBP
frequent/JJ
SNP-SNP/NN
interactions/NNS
between/IN
two/CD
genes/NNS
(/(
>/JJR
10/CD
)/)
./.
====================
GO/NN
,/,
gene/NN
ontology/NN
;/:
SNP/NN
,/,
single-nucleotide/JJ
polymorphism/NN
./.
====================
Number/NN
of/IN
significant/JJ
SNP/NN
pairs/NNS
in/IN
each/DT
chromosome/NN
====================
Network/NN
topologies/NNS
for/IN
gene-gene/NN
interaction/NN
networks/NNS
for/IN
each/DT
chromosome/NN
====================
Significantly/RB
enriched/JJ
GO/NN
terms/NNS
for/IN
each/DT
chromosome/NN
====================
